Petra Fettes

407 total citations
13 papers, 273 citations indexed

About

Petra Fettes is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Petra Fettes has authored 13 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Petra Fettes's work include GDF15 and Related Biomarkers (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Glaucoma and retinal disorders (3 papers). Petra Fettes is often cited by papers focused on GDF15 and Related Biomarkers (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Glaucoma and retinal disorders (3 papers). Petra Fettes collaborates with scholars based in Germany, Switzerland and Spain. Petra Fettes's co-authors include Sigrun Knöchel, Joachim H. Clement, Walter Knöchel, Eugen Leo, J. Häcker, Katharina Bell, Bogomil Voykov, Norbert Pfeiffer, Katrin Lorenz and Barbara Wilhelm and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Petra Fettes

13 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Fettes Germany 7 182 78 56 32 31 13 273
Takanori Onouchi Japan 10 104 0.6× 6 0.1× 60 1.1× 3 0.1× 11 0.4× 25 277
Fiona Harper United Kingdom 6 82 0.5× 3 0.0× 51 0.9× 65 2.0× 10 0.3× 9 223
Quincy Prescott United Kingdom 8 181 1.0× 6 0.1× 7 0.1× 95 3.0× 87 2.8× 10 296
Fenny Wiradjaja Australia 9 178 1.0× 5 0.1× 21 0.4× 5 0.2× 15 0.5× 9 287
Hannah Greenfeld United States 6 283 1.6× 63 0.8× 135 2.4× 3 0.1× 6 479
Brendan Roome Australia 6 118 0.6× 9 0.1× 181 3.2× 124 4.0× 6 332
Justine Nuytens Belgium 6 489 2.7× 17 0.2× 24 0.4× 5 0.2× 9 576
Marina Goldoni Italy 4 234 1.3× 20 0.3× 93 1.7× 1 0.0× 2 0.1× 18 362
Rosemary Dawson United Kingdom 8 109 0.6× 2 0.0× 190 3.4× 155 4.8× 41 1.3× 15 392
Urszula Liwak Canada 10 286 1.6× 12 0.2× 31 0.6× 3 0.1× 13 359

Countries citing papers authored by Petra Fettes

Since Specialization
Citations

This map shows the geographic impact of Petra Fettes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Fettes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Fettes more than expected).

Fields of papers citing papers by Petra Fettes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Fettes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Fettes. The network helps show where Petra Fettes may publish in the future.

Co-authorship network of co-authors of Petra Fettes

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Fettes. A scholar is included among the top collaborators of Petra Fettes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Fettes. Petra Fettes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Necchi, Andrea, Massimo Di Maïo, Paolo Gontero, et al.. (2024). Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC): A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (GDFather-Neo).. Journal of Clinical Oncology. 42(4_suppl). TPS712–TPS712. 1 indexed citations
2.
Melero, Ignacio, Maria J. de Miguel, Guzmán Alonso, et al.. (2023). Initial results from the phase 2A trial of visugromab (CTL-002) + nivolumab in advanced/metastatic anti-PD1/-L1 relapsed/refractory solid tumors (The GDFATHER-TRIAL).. Journal of Clinical Oncology. 41(16_suppl). 2501–2501. 7 indexed citations
3.
Necchi, Andrea, Massimo Di Maïo, Paolo Gontero, et al.. (2023). Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC): A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (NEO-GDFATHER).. Journal of Clinical Oncology. 41(6_suppl). TPS595–TPS595. 1 indexed citations
4.
5.
Melero, Ignacio, Emiliano Calvo, Reinhard Dummer, et al.. (2021). A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER).. Journal of Clinical Oncology. 39(15_suppl). TPS2658–TPS2658. 5 indexed citations
6.
Voykov, Bogomil, Hagen Thieme, Katharina Bell, et al.. (2017). Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery. Investigative Ophthalmology & Visual Science. 58(8). 5577–5577. 3 indexed citations
7.
8.
Hasenbach, Kathy, Tine Van Bergen, Evelien Vandewalle, et al.. (2016). Potent and selective antisense oligonucleotides targeting the transforming growth factor beta (TGF-β) isoforms in advanced glaucoma: a preclinical evaluation. 1(2). 20–28. 6 indexed citations
9.
Fiedler, Walter, Birgit Ritter, Ruth Seggewiss, et al.. (2010). Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer.. Journal of Clinical Oncology. 28(15_suppl). 2573–2573. 15 indexed citations
10.
Fiedler, Walter, Dirk Hönemann, Birgit Ritter, et al.. (2009). 1254 Safety and pharmacology of the EpCAM/CD3−bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric or lung cancer. European Journal of Cancer Supplements. 7(2). 136–137. 2 indexed citations
11.
Fettes, Petra. (2001). Overexpresssion of a homologue of the regulator affects cell size, flagellation, and pigmentation. International Journal of Medical Microbiology. 291(5). 353–360. 71 indexed citations
12.
Fettes, Petra, Milorad Šuša, J. Häcker, & R. Marre. (2000). Characterization of the Legionella pneumophila gene ligA. International Journal of Medical Microbiology. 290(3). 239–250. 16 indexed citations
13.
Clement, Joachim H., et al.. (1995). Bone morphogenetic protein 2 in the early development of Xenopus laevis. Mechanisms of Development. 52(2-3). 357–370. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanori Onouchi Breakdown of academic impact, for papers by Fiona Harper Breakdown of academic impact, for papers by Quincy Prescott Breakdown of academic impact, for papers by Fenny Wiradjaja Breakdown of academic impact, for papers by Hannah Greenfeld Breakdown of academic impact, for papers by Brendan Roome Breakdown of academic impact, for papers by Justine Nuytens Breakdown of academic impact, for papers by Marina Goldoni Breakdown of academic impact, for papers by Rosemary Dawson Breakdown of academic impact, for papers by Urszula Liwak
Rankless by CCL
2026